Jason WasiakPatrick MaharSiobhan McGuinnessAnneliese SpinksStefan DanillaHeather Cleland2026-03-222026-03-22201210.1002/14651858.cd005622.pub3https://doi.org/10.1002/14651858.cd005622.pub3https://andeanlibrary.org/handle/123456789/85883Citaciones: 18As current clinical evidence is based on only one single RCT as well as case series and reports, intravenous lidocaine must be considered a pharmacological agent under investigation in burns care, the effectiveness of which is yet to be determined with further well-designed and conducted clinical trials.enMedicineLidocainePlaceboOpioidCochrane LibraryAnesthesiaClinical trialBurn injuryRandomized controlled trialMorphinereview